View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


Dr Joris Van Dam, Novartis Appointed Chair of the Inaugural Mobile and Clinical Trials Event

  • June 6, 2014

  • The Conference Forum is thrilled to announce the appointment of Joris Van Dam, PhD, Strategic Projects Leader, Pharmaceutical Development at Novartis as the Chair for the inaugural Mobile and Clinical Trials event. This new one-day program taking place September 10th in Boston helps drug developers get their arms around the mobile/digital clinical trial landscape. Topics addressed include how mobile is innovating clinical trials, overcoming behavioral and technical hurdles, the investment climate, the true value of mobile to clinical trials, amongst others.


    Joris van Dam B&W

    Joris is a corporate entrepreneur in pharmaceutical R&D, focusing on clinical trial innovation and improving health outcomes through the use of disruptive technologies. For the past three years, he started a number of initiatives under the “Trials of the Future” program at Novartis, including the Patients-2-Trials Consortium, and the Clinical Research Collaboration with Walgreens. Prior to that, Joris spent seven years at Johnson & Johnson and seven years in consulting and business development.


    For more information about the Mobile and Clinical Trials event, please visit,